$ 92.45
Key Takeaways
Risk factor
Low price volatility
Profitability factor
Strong margins and returns
About
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive
Target Price
The average target price of LMAT is 109 and suggests 18% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
